Pioglitazone and metformin sustained release

Pioglitazone and metformin sustained release
PIOSTERIS M 500  are two antidiabetic medications commonly used in the treatment of type 2 diabetes mellitus. They are often prescribed in combination to improve glycemic control and manage blood sugar levels.
Here are some key points about PIOSTERIS M 500 :
Indications: PIOSTERIS M 500  are used to manage blood sugar levels in individuals with type 2 diabetes mellitus. They are typically prescribed when diet and exercise alone are insufficient to control blood sugar levels. The combination of these medications helps address multiple aspects of glucose regulation and insulin sensitivity.
Pioglitazone: Pioglitazone belongs to the class of drugs known as thiazolidinediones. PIOSTERIS M 500  improves insulin sensitivity by activating peroxisome proliferator-activated receptor-gamma (PPAR-gamma) receptors. Pioglitazone helps reduce insulin resistance and enhance glucose utilization in the body.
Metformin sustained release: Metformin is a biguanide medication that works by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues. It also helps lower blood sugar levels by decreasing intestinal absorption of glucose and increasing glucose uptake by muscle cells.
Combination use: PIOSTERIS M 500  are often prescribed together as a combination therapy to achieve better glycemic control. By targeting different mechanisms of action, the combination helps address insulin resistance, reduce hepatic glucose production, and enhance glucose utilization.
Administration: PIOSTERIS M 500  are available in tablet form. The dosage and frequency of administration will depend on the individual's blood sugar levels and response to the medication. It is important to follow the prescribed instructions and consult a healthcare professional for guidance on the appropriate dosage and administration.
Effectiveness: The combination of PIOSTERIS M 500  has been found to be effective in improving glycemic control in individuals with type 2 diabetes mellitus. It can help reduce HbA1c levels and improve insulin sensitivity. However, individual response to treatment may vary, and close monitoring of blood sugar levels and other relevant parameters is important.
Side effects: PIOSTERIS M 500  may have side effects, although they are generally well-tolerated. Common side effects may include gastrointestinal symptoms such as nausea, diarrhea, and abdominal discomfort. Pioglitazone may cause weight gain and fluid retention, while metformin can sometimes lead to gastrointestinal disturbances. It is important to report any concerning side effects to a healthcare professional.
Precautions: PIOSTERIS M 500  should be used with caution in individuals with certain medical conditions or a history of specific complications. It is important to inform the healthcare professional about all current medications being taken to avoid potential drug interactions.
For further information please contact:
info@sterispharma.com
order now: - https://www.sterisonline.com/product/piosteris-m-500-134243